The COVID Project
The record
- Jurisdiction
- United States Patent and Trademark Office (nationwide)
- Level
- Federal
- Authority
- 37 C.F.R. 1.183; 37 C.F.R. 2.146; 35 U.S.C. 41(a)(7)
- Issued
- 2020-03-16 Mar. 16, 2020
- Effective
- 2020-03-16
- End
- Continuing (fee waivers for COVID-caused abandonments; later notices extended the petition-to-revive relief) (read as 2021-09-30)
- In force
- Mar. 16, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Courts and public officesOther
- Addressees
- patent and trademark applicants, patentees, reexamination parties and trademark owners
- practitioners
- Functions reached
- CT agencies (prosecution deadlines)
- CS client representation (patent and trademark practice)
- PJ product launches and licensing dependent on prosecution
- CB inventors, small businesses and brand owners
- Collection
- Federal lands, science agencies and courts AGY-FED-LANDS-SCIENCE-COURTS
Operative words
The United States Patent and Trademark Office (USPTO) considers the effects of the Coronavirus outbreak that began in approximately January 2020 to be an 'extraordinary situation' within the meaning of 37 CFR 1.183 and 37 CFR 2.146 for affected patent and trademark applicants, patentees, reexamination parties, and trademark owners.... For patent applicants or patent owners who were unable to timely reply to an Office communication due to the effects of the coronavirus outbreak, which resulted in the application being held abandoned or the reexamination prosecution terminated or limited, the USPTO will waive the petition fee in 37 CFR 1.17(m) when the patent applicant or patent owner files the reply with a petition under 37 CFR 1.137(a).
Enforcement
Agency rule-suspension under 37 C.F.R. 1.183 and 2.146
Notes
The agency's own finding of an 'extraordinary situation' from January 2020 for the entire IP-owning economy.